Often, drug development has focused on tiny molecules, but peptidic partners are progressively receiving attention. This novel strategy utilizes combining peptidic sequences with other medicinal methods to address intricate disease mechanisms. By employing the unique properties of amino acid sequences – such as significant selectivity and bioavai